Bank of New York Mellon’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bank of New York Mellon’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,475	Closed	-$127K	–	4373
2018 Q1	$127K	Buy	+12,475	New	+$105K	﹤0.01%	4016
2017 Q4	–	Sell	-10,958	Closed	-$50K	–	4433
2017 Q3	$50K	Buy	+10,958	New	+$51.5K	﹤0.01%	4102
2016 Q4	–	Sell	-10,579	Closed	-$59K	–	4339
2016 Q3	$59K	Sell	10,579 -1,781	-14%	-$11.8K	﹤0.01%	4115
2016 Q2	$87K	Hold	12,360	–	–	﹤0.01%	4086
2016 Q1	$82K	Hold	12,360	–	–	﹤0.01%	4001
2015 Q4	$127K	Hold	12,360	–	–	﹤0.01%	4000
2015 Q3	$146K	Buy	+12,360	New	+$137K	﹤0.01%	4005

Other funds holding JNP

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

MERSOM

Municipal Employees' Retirement System of Michigan Lansing, Michigan $9.05B AUM 13.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bank of New York Mellon's JNP Position: Q2 2018 in Review

Bank of New York Mellon sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q2 2018, closing a stake of 12,475 shares — an estimated $127K sold.

Bank of New York Mellon first reported a position in JNP in Q3 2015 and held it in 7 quarters. The position peaked at $146K in Q3 2015. 48 funds tracked by Wall St. Rank hold JNP as of Q2 2018.

Bank of New York Mellon reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Bank of New York Mellon sold 12,475 Juniper Pharmaceuticals, Inc. Common Stock shares in Q2 2018, an estimated $127K.
Bank of New York Mellon first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2015 and held it in 7 quarters.
Bank of New York Mellon's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $146K in Q3 2015.
48 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q2 2018.

Based on Bank of New York Mellon's 13F filing for Q2 2018, filed 6 Aug 2018.